News

The July 24 event aims to inspire accessible and impactful philanthropy by breaking down barriers to meaningful change.
Assembly Biosciences, Inc. (NASDAQ:ASMB) is among the best growth stocks to invest in for the next 5 years. In the wake of ...
This article discusses the DOJ’s growing crackdown on healthcare fraud, focusing on illegal speaker programs like Gilead’s $202 million settlement. It stresses the importance of strong compliance, ...
A novel chimeric antigen receptor T-cell therapy may benefit patients with B-cell lymphomas who previously relapsed following CD19-directed CAR-T, according to results of a phase 1 study.More than 80% ...
"Ligand has been an incredible partner over the past few years, and we look forward to their continued guidance and support ...
Dr Reddy’s Laboratories prepares for US market challenges with strategic growth initiatives and strong financial performance in FY25.
Pfizer has terminated a Phase II study of its CD47 immune checkpoint inhibitor, maplirpacept, due to low recruitment. In an ...